Seroba Life Sciences

Seroba Life Sciences is a European venture capital firm specializing in the life sciences sector, focusing on investments in innovative biotech and medtech companies. The firm is headquartered in Dublin, Ireland, with additional offices in Paris and Milan. Seroba's mission is to create value by supporting breakthrough healthcare technologies that address unmet medical needs and improve patient outcomes.

The firm's investment strategy targets early-stage companies, typically at Series A and B stages, with a geographical focus on Western Europe and selective investments in North America. Seroba's portfolio spans various sectors within the life sciences industry, including biotechnology, medical devices, pharmaceuticals, diagnostics, and medtech. The firm has a history of backing companies that develop cutting-edge solutions in these areas.

Seroba Life Sciences has successfully raised multiple funds, with its fourth fund, Seroba Fund IV, closing at €123 million in February 2024. This fund aims to make up to 12 investments, with a focus on early-stage life sciences innovations. The firm has a track record of supporting companies from inception through development, clinical evaluation, and market launch, partnering with leading pharmaceutical and medtech companies to bring innovative products to market.